Nebius Announces AI Discovery Awards Winners
Analysis based on 8 articles · First reported Jul 02, 2026 · Last updated Jul 02, 2026
The event highlights the increasing integration of AI in the healthcare and life sciences sectors, potentially driving innovation and investment in these areas. Nebius Group's stock may see positive sentiment due to its leadership in fostering AI development and its new platform offering.
Nebius Group, an AI cloud company, announced the winners of its 2026 AI Discovery Awards, recognizing leading startups that leverage AI in healthcare and life sciences. The program expanded to include Medical Devices and Medical Imaging categories, alongside BioPharma, Genomics, and Digital Health. Winners in each category, such as Phylo, Corti, Omniscope, Real-Time Imaging Systems, and Nucleo Research, received $100,000 in compute and inference credits. Regional Trailblazer awards were also introduced, with Check Me, Hummingbird Bioscience, Owkin, Arkangel AI, and Xaira Therapeutics receiving $30,000 in credits. Additionally, Nebius Group previewed its Scientific AI and Healthcare Platform, an AI cloud infrastructure designed for healthcare and life sciences organizations.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard